Participated · Series A · Mar 2026

AvoMD builds a clinical AI platform designed to synthesize patient data, surface evidence-based guidance, and support clinicians with end-to-end AI copilots embedded in the EHR. The company positions its product to reduce clinician friction caused by fragmented datasets and multiple applications, aiming to drive measurable improvements in outcomes, cost savings, revenue, and operational efficiency. AvoMD announced a strategic partnership with DynaMed from EBSCO Clinical Decisions to integrate trusted evidence-based knowledge into the EHR via Ask Avo. The business emphasized clinician-centric design, saying it delivers results “with love, not alerts.” Financially, AvoMD has secured a $10M Series A to accelerate product development and commercialization. The announcement credits engaged customers, partners, and its team for supporting the company's growth.

Participated · Series B · Jan 2025

KODE operates an on-demand marketplace and the KODE Management Platform that connects hospitals and providers to a community of certified medical coders (“Koders”) while combining AI-driven tools with human expertise. The platform is designed to accelerate collections and reduce staffing costs by addressing inefficiencies in traditional medical coding workflows. KODE plans to expand its network of certified coding professionals and further develop AI and predictive-analytics capabilities to move beyond staffing into technology-first revenue cycle solutions. The company reports coding over a quarter million medical records per month and a community of more than 5,500 certified coding professionals who have coded over 8 million records to date. KODE says it has achieved consistent operational profitability. The product roadmap emphasizes additional investment in product development, platform enhancements, and scaling its team of Koders.

Participated · Series A · Jun 2024

Marigold Health offers a proprietary peer support program that pairs one-on-one coaching from certified peer specialists with 24/7 text-based support groups in an app integrated with NLP that flags health needs in chats. The company has demonstrated real-world outcomes: a 2020–22 pilot with a major managed Medicaid organization in Delaware made Marigold the state’s largest provider of peer recovery supports, and an outcomes analysis of 1,000 app signups found 98% reported improvement in at least one dimension of Recovery Capital. Today the program covers about 25,000 members across Delaware, Rhode Island, and Massachusetts. Marigold is prioritizing partnerships with Medicaid and duals health plans and is pursuing a value-based reimbursement model to tie improved member outcomes to lower total healthcare costs. The company plans to grow its peer workforce, continue developing its NLP, expand to at least four additional states by the end of next year, and pursue a longer-term vision of a nationally distributed peer delivery model that can support chronic conditions beyond SUD. Marigold Health runs a virtual program that uses trained peers—individuals in recovery—to support others via 24/7 text-based group chats. The company has patented natural language processing technology to help peers moderate its online community and has validated the approach in federally funded studies. A NIDA-funded Phase I study of 50 patients with opioid use disorder reported 64% daily use of the Marigold app across a two-month period. Since 2016 Marigold has engaged thousands of patients and reports that over 75% of current members are on public health insurance. Its service has been adopted by health plans and providers—AmeriHealth Caritas DE offered Marigold to more than 10,000 members with SUD, and Wood River Health Services will offer it in Rhode Island. Marigold plans to build state-level peer workforces and pursue Medicaid plan partnerships to expand access in communities affected by the opioid epidemic.

Participated · Series A · Apr 2024

Praia Health operates a consumer experience orchestration platform that identifies patients with lab orders and delivers tailored notifications and cards within a health system’s mobile app or logged-in web experience. The platform enables patients to schedule lab tests ordered by their physicians and find the closest appropriate Labcorp facility, accounting for service availability, operating hours, and staffing. Praia announced a strategic investment and collaboration with the Labcorp Venture Fund to streamline and personalize the patient experience for lab orders and testing within select health systems. The collaboration will initially launch at Providence’s Puget Sound location. The article does not disclose revenue, user metrics, or the investment amount. Praia Health is a Seattle-based digital health company and consumer platform for health systems that aims to deliver individualized health solutions at scale. The company was incubated at Providence and is led by CEO Justin Dearborn. Praia operates an Ecosystem Partner program with seventeen digital health partners, including Atlas Health, Cedar, DexCare, Foodsmart, Omada Health and others. Xealth serves as Praia Health’s clinical integration partner and brings over 50 additional connected digital health partners into the company’s ecosystem. Praia has also secured channel partners including Panda Health, the AVIA Marketplace, Xealth, and West Monroe. The company raised $20M in a Series A to bolster the platform’s capabilities.

Participated · Series B · Jun 2023

Axuall operates a workforce intelligence platform that aggregates clinician data through a national, real-time practitioner data network. Its Workforce Intelligence Network pulls clinician information from nearly 7,000 data sources and directly from physicians, advanced practice providers, and nurses via an integrated digital credential wallet with smart applications. The platform is used to reduce onboarding and enrollment time for healthcare systems, staffing firms, telehealth providers, and health plans while supplying data insights for network planning, analytics, and reporting. Axuall’s technology connects to the systems, vendors, and processes that customers already use. Led by co-founder and CEO Charlie Lougheed, the company has raised over $41M from more than two dozen healthcare organizations. It most recently announced an undisclosed Series B-1 that added Frist Cressey Ventures following a $20M Series B in May 2023. Axuall provides workforce intelligence powered by a national real-time practitioner data network, enabling healthcare systems, staffing firms, telehealth companies, and health plans to reduce onboarding and enrollment time while offering data insights for planning, analytics, and reporting. Led by CEO Charlie Lougheed, the company’s technology integrates with credentialing and recruiting workflows to streamline practitioner management. Axuall’s network today consists of over 6,800 primary data sources. The company recently raised $20M in a Series B to support growth. Axuall intends to use the funds to grow its product, sales, and marketing teams and to develop its data partnerships across its network. It also plans to accelerate API integration into planning, recruiting, credentialing, enrollment, CRM, and electronic medical record systems. Axuall operates a national digital professional identity network that enables clinicians, healthcare systems, staffing firms, telehealth groups, and health plans to share and manage authenticated provider credentials and qualifications in real time. Built on a provider-centric model, the network aims to eliminate onboarding delays, reduce physician burnout, and enable workforce intelligence across the healthcare industry. The solution was developed and piloted with University Hospitals, MedStar Health, and MetroHealth and launched commercially in late 2020. Axuall was formed in 2018 and initially raised $3 million of venture funding to develop the network. The company plans to use new capital to accelerate R&D, implementations, sales, and marketing as it grows its customer base of healthcare organizations. Management positions the product as addressing provider data delays and blind spots that drive billions in annual costs and care inefficiencies. Axuall operates a real-time digital network for verifying identity, credentials, and authenticity to eliminate waste, prevent fraud, and manage risk in healthcare, financial services, manufacturing, government, and other sectors. The network enables healthcare providers to request and receive digitally signed credentials from primary sources and securely share them with employers, health systems, and insurance plans. Axuall proactively monitors conditional events such as expirations and dependencies so practitioners can address issues as they arise, keeping credentials up-to-date and aligned with standards. Led by CEO Charlie Lougheed and based in Cleveland, OH, the company is preparing for commercial release. Axuall recently closed a $3M seed financing to support its near-term plans. The company intends to use the funds to hire additional software engineering and product personnel, run several large-scale pilots, develop its partner network, and complete R&D for commercial release.